Working while your claim is pending can be complicated
Feeding mutant flies the antioxidant, N-acetylcysteine amide (NACA), suppressed the neurodegeneration caused by gain-of-function mutation in ACOX1
Proc Soc Exp Biol Med
Following the FDAs ruling in September 2023, injectable BPC 157 is no longer available from compounding pharmacies due to concerns regarding its adverse risk profile
(Outlines contraindications for niacin therapy, including active peptic ulcer disease, active liver disease with elevated enzymes, hypersensitivity to niacin, and arterial bleeding, as well as monitoring recommendations for blood pressure, glucose, uric acid, etc., due to niacins systemic effects)